Noven Pharmaceuticals is recalling 22,932 cartons of Minivelle (estradiol) and generic Estradiol transdermal patches because the patches may not stick properly to the skin. This defect, caused by an out-of-specification release rate and adhesive shear, means the delivery system for the medication is compromised. If a patch does not remain securely attached, the patient may not receive the full intended dose of medication. These prescription hormone replacement therapies were distributed nationwide across the United States.
The patches are failing to meet quality standards for adhesive properties and medication release rates, which means they can peel off or fail to stick. This prevents the patient from receiving a consistent and accurate dose of estradiol, potentially leading to a recurrence of symptoms or ineffective treatment.
Contact healthcare provider or pharmacist for guidance.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.